GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) » Definitions » ROC %

Torrent Pharmaceuticals (NSE:TORNTPHARM) ROC % : 14.51% (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Torrent Pharmaceuticals ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Torrent Pharmaceuticals's annualized return on capital (ROC %) for the quarter that ended in Dec. 2023 was 14.51%.

As of today (2024-05-26), Torrent Pharmaceuticals's WACC % is 10.74%. Torrent Pharmaceuticals's ROC % is 13.74% (calculated using TTM income statement data). Torrent Pharmaceuticals generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Torrent Pharmaceuticals ROC % Historical Data

The historical data trend for Torrent Pharmaceuticals's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torrent Pharmaceuticals ROC % Chart

Torrent Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.06 11.01 12.95 10.43 12.22

Torrent Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.69 10.87 13.06 13.57 14.51

Torrent Pharmaceuticals ROC % Calculation

Torrent Pharmaceuticals's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2023 is calculated as:

ROC % (A: Mar. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2022 ) + Invested Capital (A: Mar. 2023 ))/ count )
=21400.2 * ( 1 - 32.59% )/( (105191.7 + 130827.1)/ 2 )
=14425.87482/118009.4
=12.22 %

where

Invested Capital(A: Mar. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=130998.4 - 19977.2 - ( 5829.5 - max(0, 44150.9 - 51649.9+5829.5))
=105191.7

Invested Capital(A: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=150118.5 - 20627.2 - ( 7227.5 - max(0, 54473 - 53137.2+7227.5))
=130827.1

Torrent Pharmaceuticals's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=26240 * ( 1 - 29.79% )/( (127010 + 0)/ 1 )
=18423.104/127010
=14.51 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Torrent Pharmaceuticals  (NSE:TORNTPHARM) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Torrent Pharmaceuticals's WACC % is 10.74%. Torrent Pharmaceuticals's ROC % is 13.74% (calculated using TTM income statement data). Torrent Pharmaceuticals generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Torrent Pharmaceuticals ROC % Related Terms

Thank you for viewing the detailed overview of Torrent Pharmaceuticals's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Torrent Pharmaceuticals (NSE:TORNTPHARM) Business Description

Traded in Other Exchanges
Address
Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, and gastrointestinal therapeutic areas. It operates through Generic Formulation Business segments. Geographically, the business activities are carried out across Indian and International markets.

Torrent Pharmaceuticals (NSE:TORNTPHARM) Headlines

No Headlines